Willis Investment Counsel Organon & Co. Transaction History

Willis Investment Counsel

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$10.95 - $17.32 $1,697 - $2,684	-155 Reduced 1.4%	10,886 $156,000
Q3 2023 Mar 07, 2024	SELL	$16.59 - $23.77 $121,919 - $174,685	-7,349 Reduced 39.96%	11,041 $191,000
Q3 2023 Oct 17, 2023	SELL	$16.59 - $23.77 $121,919 - $174,685	-7,349 Reduced 39.96%	11,041 $191,000
Q2 2023 Mar 07, 2024	BUY	$19.27 - $24.63 $46,016 - $58,816	2,388 Added 14.92%	18,390 $382,000
Q2 2023 Jul 11, 2023	BUY	$19.27 - $24.63 $46,016 - $58,816	2,388 Added 14.92%	18,390 $382,000
Q1 2023 Mar 07, 2024	BUY	$21.42 - $32.08 $109,584 - $164,121	5,116 Added 47.0%	16,002 $376,000
Q1 2023 Apr 18, 2023	BUY	$21.42 - $32.08 $97,846 - $146,541	4,568 Added 39.95%	16,002 $376,000
Q4 2022 Jan 18, 2023	SELL	$23.31 - $28.61 $44,522 - $54,645	-1,910 Reduced 14.31%	11,434 $0
Q3 2022 Oct 12, 2022	SELL	$23.4 - $34.25 $260,231 - $380,894	-11,121 Reduced 45.46%	13,344 $312,000
Q2 2022 Aug 08, 2022	BUY	$31.66 - $38.9 $273,764 - $336,368	8,647 Added 54.67%	24,465 $826,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $7,825 - $10,115	-257 Reduced 1.6%	15,818 $553,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $460,870 - $596,864	16,075 New	16,075 $489,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.02B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.